180 related articles for article (PubMed ID: 29284494)
1. Ferumoxytol enhanced black-blood cardiovascular magnetic resonance imaging.
Nguyen KL; Park EA; Yoshida T; Hu P; Finn JP
J Cardiovasc Magn Reson; 2017 Dec; 19(1):106. PubMed ID: 29284494
[TBL] [Abstract][Full Text] [Related]
2. High resolution, 3-dimensional Ferumoxytol-enhanced cardiovascular magnetic resonance venography in central venous occlusion.
Shahrouki P; Moriarty JM; Khan SN; Bista B; Kee ST; DeRubertis BG; Yoshida T; Nguyen KL; Finn JP
J Cardiovasc Magn Reson; 2019 Mar; 21(1):17. PubMed ID: 30853026
[TBL] [Abstract][Full Text] [Related]
3. 4D MUSIC CMR: value-based imaging of neonates and infants with congenital heart disease.
Nguyen KL; Han F; Zhou Z; Brunengraber DZ; Ayad I; Levi DS; Satou GM; Reemtsen BL; Hu P; Finn JP
J Cardiovasc Magn Reson; 2017 Apr; 19(1):40. PubMed ID: 28366171
[TBL] [Abstract][Full Text] [Related]
4. Ferumoxytol as an off-label contrast agent in body 3T MR angiography: a pilot study in children.
Ruangwattanapaisarn N; Hsiao A; Vasanawala SS
Pediatr Radiol; 2015 Jun; 45(6):831-9. PubMed ID: 25427433
[TBL] [Abstract][Full Text] [Related]
5. 4D flow image quality with blood pool contrast: a comparison of gadofosveset trisodium and ferumoxytol.
Mukai K; Burris NS; Mahadevan VS; Foster ED; Ordovas KG; Hope MD
Int J Cardiovasc Imaging; 2018 Feb; 34(2):273-279. PubMed ID: 28884401
[TBL] [Abstract][Full Text] [Related]
6. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
7. Macrophage Imaging of Cerebral Aneurysms with Ferumoxytol: an Exploratory Study in an Animal Model and in Patients.
Aoki T; Saito M; Koseki H; Tsuji K; Tsuji A; Murata K; Kasuya H; Morita A; Narumiya S; Nozaki K;
J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2055-2064. PubMed ID: 28774792
[TBL] [Abstract][Full Text] [Related]
8. Improved high-resolution pediatric vascular cardiovascular magnetic resonance with gadofosveset-enhanced 3D respiratory navigated, inversion recovery prepared gradient echo readout imaging compared to 3D balanced steady-state free precession readout imaging.
Tandon A; Hashemi S; Parks WJ; Kelleman MS; Sallee D; Slesnick TC
J Cardiovasc Magn Reson; 2016 Nov; 18(1):74. PubMed ID: 27802802
[TBL] [Abstract][Full Text] [Related]
9. Intermodality feature fusion combining unenhanced computed tomography and ferumoxytol-enhanced magnetic resonance angiography for patient-specific vascular mapping in renal impairment.
Yoshida T; Nguyen KL; Shahrouki P; Quinones-Baldrich WJ; Lawrence PF; Finn JP
J Vasc Surg; 2020 May; 71(5):1674-1684. PubMed ID: 31734117
[TBL] [Abstract][Full Text] [Related]
10. Brand ferumoxytol vs. generic ferumoxytol comparison across two dosing regimens: a cardiac MRI image quality study.
Dasi A; Kring DN; Selvaraj B; Morgan P; Gerity C; Morgan EE; Krishnamurthy R; Krishnamurthy R
Pediatr Radiol; 2023 Dec; 53(13):2622-2632. PubMed ID: 37837456
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive motion-compensated highly accelerated 4D flow MRI with ferumoxytol enhancement for pediatric congenital heart disease.
Cheng JY; Hanneman K; Zhang T; Alley MT; Lai P; Tamir JI; Uecker M; Pauly JM; Lustig M; Vasanawala SS
J Magn Reson Imaging; 2016 Jun; 43(6):1355-68. PubMed ID: 26646061
[TBL] [Abstract][Full Text] [Related]
12. Black-blood thrombus imaging (BTI): a contrast-free cardiovascular magnetic resonance approach for the diagnosis of non-acute deep vein thrombosis.
Xie G; Chen H; He X; Liang J; Deng W; He Z; Ye Y; Yang Q; Bi X; Liu X; Li D; Fan Z
J Cardiovasc Magn Reson; 2017 Jan; 19(1):4. PubMed ID: 28095878
[TBL] [Abstract][Full Text] [Related]
13. Ferumoxytol-enhanced cardiovascular magnetic resonance detection of early stage acute myocarditis.
Tada Y; Tachibana A; Heidary S; Yang PC; McConnell MV; Dash R
J Cardiovasc Magn Reson; 2019 Dec; 21(1):77. PubMed ID: 31842900
[TBL] [Abstract][Full Text] [Related]
14. High-resolution three‑dimensional contrast‑enhanced magnetic resonance venography in children: comparison of gadofosveset trisodium with ferumoxytol.
Shahrouki P; Khan SN; Yoshida T; Iskander PJ; Ghahremani S; Finn JP
Pediatr Radiol; 2022 Mar; 52(3):501-512. PubMed ID: 34936018
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic safety and efficacy of ferumoxytol as an intravenous contrast agents in pediatric patients and young adults.
Ning P; Zucker EJ; Wong P; Vasanawala SS
Magn Reson Imaging; 2016 Feb; 34(2):152-8. PubMed ID: 26518061
[TBL] [Abstract][Full Text] [Related]
16. Impact of ferumoxytol vs gadolinium on 4D flow cardiovascular magnetic resonance measurements in small children with congenital heart disease.
Kollar SE; Udine ML; Mandell JG; Cross RR; Loke YH; Olivieri LJ
J Cardiovasc Magn Reson; 2022 Nov; 24(1):58. PubMed ID: 36352454
[TBL] [Abstract][Full Text] [Related]
17. Lower extremity deep venous thrombosis: evaluation with ferumoxytol-enhanced MR imaging and dual-contrast mechanism--preliminary experience.
Li W; Salanitri J; Tutton S; Dunkle EE; Schneider JR; Caprini JA; Pierchala LN; Jacobs PM; Edelman RR
Radiology; 2007 Mar; 242(3):873-81. PubMed ID: 17325072
[TBL] [Abstract][Full Text] [Related]
18. High-resolution 3D volumetric contrast-enhanced MR angiography with a blood pool agent (ferumoxytol) for diagnostic evaluation of pediatric brain arteriovenous malformations.
Iv M; Choudhri O; Dodd RL; Vasanawala SS; Alley MT; Moseley M; Holdsworth SJ; Grant G; Cheshier S; Yeom KW
J Neurosurg Pediatr; 2018 Sep; 22(3):251-260. PubMed ID: 29882734
[TBL] [Abstract][Full Text] [Related]
19. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
[TBL] [Abstract][Full Text] [Related]
20. Incidental findings in cardiac magnetic resonance imaging: superiority of bSSFP over T1w-HASTE for extra-cardiac findings assessment.
Sohns JM; Menke J; Schwarz A; Bergau L; Kowallick JT; Schuster A; Konietschke F; Placzek M; Weiberg D; Nordlohne S; Schmuck S; Schulz S; Derlin T; Staab W
Int J Cardiovasc Imaging; 2017 Oct; 33(10):1581-1587. PubMed ID: 28451954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
